• 25961 Citations
  • 64 h-Index
1986 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Article
2020

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

Marks, D. K., Gartrell, R. D., El Asmar, M., Boboila, S., Hart, T., Lu, Y., Pan, Q., Yu, J., Hibshoosh, H., Guo, H., Andreopoulou, E., Wiechmann, L., Crew, K., Sparano, J., Hershman, D., Connolly, E., Saenger, Y. & Kalinsky, K., Jun 16 2020, In : Frontiers in Oncology. 10, 968.

Research output: Contribution to journalArticle

Open Access

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

Mehta, V., Goel, S., Kabarriti, R., Cole, D., Goldfinger, M., Acuna-Villaorduna, A., Pradhan, K., Thota, R., Reissman, S., Sparano, J. A., Gartrell, B. A., Smith, R. V., Ohri, N., Garg, M., Racine, A. D., Kalnicki, S., Perez-Soler, R., Halmos, B. & Verma, A., Jul 1 2020, In : Cancer discovery. 10, 7, p. 935-941 7 p.

Research output: Contribution to journalArticle

Open Access
52 Scopus citations

Clinical Outcomes in Early Breast Cancer with a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial

Sparano, J. A., Gray, R. J., Makower, D. F., Albain, K. S., Saphner, T. J., Badve, S. S., Wagner, L. I., Kaklamani, V. G., Keane, M. M., Gomez, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Toppmeyer, D. L., Brufsky, A. M., Goetz, M. P., Berenberg, J. L., Mahalcioiu, C., Desbiens, C., Hayes, D. F. & 9 others, Dees, E. C., Geyer, C. E., Olson, J. A., Wood, W. C., Lively, T., Paik, S., Ellis, M. J., Abrams, J. & Sledge, G. W., Mar 2020, In : JAMA Oncology. 6, 3, p. 367-374 8 p.

Research output: Contribution to journalArticle

Open Access
13 Scopus citations

Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers

Lin, L. L., Lakomy, D. S., Chiao, E. Y., Strother, R. M., Wirth, M., Cesarman, E., Borok, M., Busakhala, N., Chibwesha, C. J., Chinula, L., Ndlovu, N., Orem, J., Phipps, W., Sewram, V., Vogt, S. L., Sparano, J. A., Mitsuyasu, R. T., Krown, S. E. & Gopal, S., Jul 1 2020, In : JCO global oncology. 6, p. 1134-1146 13 p.

Research output: Contribution to journalArticle

Open Access

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

Wagner, L. I., Gray, R. J., Sparano, J. A., Whelan, T. J., Garcia, S. F., Yanez, B., Tevaarwerk, A. J., Carlos, R. C., Albain, K. S., Olson, J. A., Goetz, M. P., Pritchard, K. I., Hayes, D. F., Geyer, C. E., Dees, E. C., McCaskill-Stevens, W. J., Minasian, L. M., Sledge, G. W. & Cella, D., Jun 10 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 17, p. 1875-1886 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up

Pothuri, B., Brodsky, A. L., Sparano, J. A., Blank, S. V., Kim, M., Hershman, D. L., Tiersten, A., Kiesel, B. F., Beumer, J. H., Liebes, L. & Muggia, F., Apr 1 2020, In : Cancer Chemotherapy and Pharmacology. 85, 4, p. 741-751 11 p.

Research output: Contribution to journalArticle

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study

Wesolowski, R., Stover, D. G., Lustberg, M. B., Shoben, A., Zhao, M., Mrozek, E., Layman, R. M., Macrae, E., Duan, W., Zhang, J., Hall, N., Wright, C. L., Gillespie, S., Berger, M., Chalmers, J. J., Carey, A., Balasubramanian, P., Miller, B. L., Amaya, P., Andreopoulou, E. & 8 others, Sparano, J., Shapiro, C. L., Villalona-Calero, M. A., Geyer, S., Chen, A., Grever, M. R., Knopp, M. V. & Ramaswamy, B., Aug 1 2020, In : Oncologist. 25, 8, p. e1158-e1169

Research output: Contribution to journalArticle

Open Access

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

the International Immuno-Oncology Biomarker Working Group, Dec 1 2020, In : npj Breast Cancer. 6, 1, 17.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Validation of an automated quantitative digital pathology approach for scoring tmem, a prognostic biomarker for metastasis

Entenberg, D., Oktay, M. H., D’alfonso, T., Ginter, P. S., Robinson, B. D., Xue, X., Rohan, T. E., Sparano, J. A., Jones, J. G. & Condeelis, J. S., Apr 2020, In : Cancers. 12, 4, 846.

Research output: Contribution to journalArticle

Open Access
2019

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay with Breast Ductal Carcinoma in Situ Treatment

Lehman, C. D., Gatsonis, C., Romanoff, J., Khan, S. A., Carlos, R., Solin, L. J., Badve, S., McCaskill-Stevens, W., Corsetti, R. L., Rahbar, H., Spell, D. W., Blankstein, K. B., Han, L. K., Sabol, J. L., Bumberry, J. R., Gareen, I., Snyder, B. S., Wagner, L. I., Miller, K. D., Sparano, J. A. & 1 others, Comstock, C., Jul 2019, In : JAMA Oncology. 5, 7, p. 1036-1042 7 p.

Research output: Contribution to journalArticle

5 Scopus citations

Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer

Sparano, J. A., Gray, R. J., Ravdin, P. M., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., Lively, T., Badve, S. S., Saphner, T. J., Wagner, L. I., Whelan, T. J., Ellis, M. J., Paik, S., Wood, W. C., Keane, M. M. & 10 others, Gomez Moreno, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Brufsky, A. M., Toppmeyer, D. L., Kaklamani, V. G., Berenberg, J. L., Abrams, J. & Sledge, G. W., Jun 20 2019, In : New England Journal of Medicine. 380, 25, p. 2395-2405 11 p.

Research output: Contribution to journalArticle

64 Scopus citations

Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study

Yardley, D. A., Hart, L., Favret, A., Blau, S., Diab, S., Richards, D., Sparano, J., Beck, J. T., Richards, P., Ward, P., Ramaswamy, B., Tsai, M., Blackwell, K., Pluard, T., Tolaney, S. M., Esteva, F. J., Truica, C. I., Alemany, C., Volas-Redd, G., Shtivelband, M. & 4 others, Purkayastha, D., Dalal, A. A., Miller, M. & Hortobagyi, G. N., Aug 2019, In : Clinical breast cancer. 19, 4, p. 268-277.e1

Research output: Contribution to journalArticle

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Apr 6 2019, In : The Lancet. 393, 10179, p. 1440-1452 13 p.

Research output: Contribution to journalArticle

Open Access
50 Scopus citations

Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study

Hurvitz, S. A., Martin, M., Jung, K. H., Huang, C. S., Harbeck, N., Valero, V., Stroyakovskiy, D., Wildiers, H., Campone, M., Boileau, J. F., Fasching, P. A., Afenjar, K., Spera, G., Lopez-Valverde, V., Song, C., Trask, P., Boulet, T., Sparano, J. A., Fraser Symmans, W., Thompson, A. M. & 1 others, Slamon, D., Sep 1 2019, In : Journal of Clinical Oncology. 37, 25, p. 2206-2216 11 p.

Research output: Contribution to journalArticle

Open Access
22 Scopus citations

Simulation modeling to extend clinical trials of adjuvant chemotherapy guided by a 21-gene expression assay in early breast cancer

Jayasekera, J., Sparano, J. A., Gray, R., Isaacs, C., Kurian, A., O'Neill, S., Schechter, C. B. & Mandelblatt, J., Dec 1 2019, In : JNCI Cancer Spectrum. 3, 4, pkz062.

Research output: Contribution to journalArticle

Open Access
2018

Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer

Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., Lively, T., Badve, S. S., Saphner, T. J., Wagner, L. I., Whelan, T. J., Ellis, M. J., Paik, S., Wood, W. C., Ravdin, P. M., Keane, M. M. & 10 others, Gomez Moreno, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Brufsky, A. M., Toppmeyer, D. L., Kaklamani, V. G., Berenberg, J. L., Abrams, J. & Sledge, G. W., Jul 12 2018, In : New England Journal of Medicine. 379, 2, p. 111-121 11 p.

Research output: Contribution to journalArticle

454 Scopus citations

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

Sparano, J., O'Neill, A., Alpaugh, K., Wolff, A. C., Northfelt, D. W., Dang, C. T., Sledge, G. W. & Miller, K. D., Dec 2018, In : JAMA Oncology. 4, 12, p. 1700-1706 7 p.

Research output: Contribution to journalArticle

46 Scopus citations

Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer

Pastoriza, J. M., Karagiannis, G. S., Lin, J., Lanjewar, S., Entenberg, D., Condeelis, J. S., Sparano, J. A., Xue, X., Rohan, T. E. & Oktay, M. H., Oct 1 2018, In : Clinical and Experimental Metastasis. 35, 7, p. 613-623 11 p.

Research output: Contribution to journalArticle

6 Scopus citations

Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034

Tan, C. R. C., Barta, S. K., Lee, J., Rudek, M. A., Sparano, J. A. & Noy, A., Aug 3 2018, In : Leukemia and Lymphoma. 59, 8, p. 1851-1860 10 p.

Research output: Contribution to journalArticle

4 Scopus citations

Double-blind phase III trial of adjuvant chemotherapy withand without bevacizumab in patients with lymph node-positiveand high-risk lymph node-negative breast cancer (E5103)

Miller, K. D., O'Neill, A., Gradishar, W., Hobday, T. J., Goldstein, L. J., Mayer, I. A., Bloom, S., Brufsky, A. M., Tevaarwerk, A. J., Sparano, J. A., Le-Lindqwister, N. A., Hendricks, C. B., Northfelt, D. W., Dang, C. T. & Sledge, G. W., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2621-2629 9 p.

Research output: Contribution to journalArticle

13 Scopus citations

Effects of radiotherapy in early-stage, low-recurrence risk, hormone-sensitive breast cancer

CISNET-BOLD Collaborative Group , Jan 1 2018, In : Journal of the National Cancer Institute. 110, 12, djy128.

Research output: Contribution to journalArticle

14 Scopus citations

Gene Expression Assays in Early-Stage Breast Cancer

Sparano, J. A., Oct 17 2018, In : Oncology (Williston Park, N.Y.). 32, 10

Research output: Contribution to journalArticle

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Jan 2018, In : The Lancet Oncology. 19, 1, p. 27-39 13 p.

Research output: Contribution to journalArticle

183 Scopus citations

Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

Hurvitz, S. A., Martin, M., Symmans, W. F., Jung, K. H., Huang, C. S., Thompson, A. M., Harbeck, N., Valero, V., Stroyakovskiy, D., Wildiers, H., Campone, M., Boileau, J. F., Beckmann, M. W., Afenjar, K., Fresco, R., Helms, H. J., Xu, J., Lin, Y. G., Sparano, J. & Slamon, D., Jan 2018, In : The Lancet Oncology. 19, 1, p. 115-126 12 p.

Research output: Contribution to journalArticle

87 Scopus citations

Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer

Anampa, J., Chen, A., Wright, J., Patel, M., Pellegrino, C., Fehn, K., Sparano, J. A. & Andreopoulou, E., Feb 2018, In : Clinical breast cancer. 18, 1, p. e135-e142

Research output: Contribution to journalArticle

4 Scopus citations

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial

Kalinsky, K., Sparano, J. A., Zhong, X., Andreopoulou, E., Taback, B., Wiechmann, L., Feldman, S. M., Ananthakrishnan, P., Ahmad, A., Cremers, S., Sireci, A. N., Cross, J. R., Marks, D. K., Mundi, P., Connolly, E., Crew, K. D., Maurer, M. A., Hibshoosh, H., Lee, S. & Hershman, D. L., Nov 1 2018, In : Clinical and Translational Oncology. 20, 11, p. 1474-1483 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: Results of PrE0102

Kornblum, N., Zhao, F., Manola, J., Klein, P., Ramaswamy, B., Brufsky, A., Stella, P. J., Burnette, B., Telli, M., Makower, D. F., Cheema, P., Truica, C. I., Wolff, A. C., Soori, G. S., Haley, B., Wassenaar, T. R., Goldstein, L. J., Miller, K. D. & Sparano, J. A., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1556-1563 8 p.

Research output: Contribution to journalArticle

35 Scopus citations

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies

Rakovitch, E., Gray, R., Baehner, F. L., Sutradhar, R., Crager, M., Gu, S., Nofech-Mozes, S., Badve, S. S., Hanna, W., Hughes, L. L., Wood, W. C., Davidson, N. E., Paszat, L., Shak, S., Sparano, J. A. & Solin, L. J., Jun 1 2018, In : Breast Cancer Research and Treatment. 169, 2, p. 359-369 11 p.

Research output: Contribution to journalArticle

11 Scopus citations

Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas

AIDS Malignancy Consortium, Dec 26 2018, In : Blood Advances. 2, 24, p. 3618-3626 9 p.

Research output: Contribution to journalArticle

1 Scopus citations

Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)

Ramos, J. C., Sparano, J. A., Rudek, M. A., Moore, P. C., Cesarman, E., Reid, E. G., Henry, D., Ratner, L., Aboulafia, D., Lee, J. Y., Ambinder, R. F., Mitsuyasu, R. & Noy, A., Mar 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 3, p. 180-190.e2

Research output: Contribution to journalArticle

4 Scopus citations

Simulation modeling of cancer clinical trials: Application to omitting radiotherapy in low-risk breast cancer

CISNET-BOLD Collaborative Group , 2018, In : Journal of the National Cancer Institute. 110, 12, djy059.

Research output: Contribution to journalArticle

4 Scopus citations
2017

A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)

Goldstein, L. J., Zhao, F., Wang, M., Swaby, R. F., Sparano, J. A., Meropol, N. J., Bhalla, K. N., Pellegrino, C. M., Katherine Alpaugh, R., Falkson, C. I., Klein, P. & Sledge, G. W., Jun 16 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-8 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

Cetuximab plus chemoradiotherapy for HIV-associated anal carcinoma: A phase II AIDS malignancy consortium trial

Sparano, J. A., Lee, J. Y., Palefsky, J., Henry, D. H., Wachsman, W., Rajdev, L., Aboulafia, D., Ratner, L., Fitzgerald, T. J., Kachnic, L. & Mitsuyasu, R., Mar 1 2017, In : Journal of Clinical Oncology. 35, 7, p. 727-733 7 p.

Research output: Contribution to journalArticle

29 Scopus citations

Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: A phase II Eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)

Garg, M. K., Zhao, F., Sparano, J. A., Palefsky, J., Whittington, R., Mitchell, E. P., Mulcahy, M. F., Armstrong, K. I., Nabbout, N. H., Kalnicki, S., El-Rayes, B. F., Onitilo, A. A., Moriarty, D. J., Fitzgerald, T. J. & Benson, A. B., Mar 1 2017, In : Journal of Clinical Oncology. 35, 7, p. 718-726 9 p.

Research output: Contribution to journalArticle

32 Scopus citations

Efficacy of the PARP inhibitor veliparib with carboplatin or as a single agent in patients with germline BRCA1- or BRCA2-associated metastatic breast cancer: California Cancer Consortium trial NCT01149083

Somlo, G., Frankel, P. H., Arun, B. K., Ma, C. X., Garcia, A. A., Cigler, T., Cream, L. V., Harvey, H. A., Sparano, J. A., Nanda, R., Chew, H. K., Moynihan, T. J., Vahdat, L. T., Goetz, M. P., Beumer, J. H., Hurria, A., Mortimer, J., Piekarz, R., Sand, S., Herzog, J. & 7 others, Van Tongeren, L. R., Ferry-Galow, K. V., Chen, A. P., Ruel, C., Newman, E. M., Gandara, D. R. & Weitzel, J. N., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4066-4076 11 p.

Research output: Contribution to journalArticle

42 Scopus citations

Genome-wide association study for anthracycline-induced congestive heart failure

Schneider, B. P., Shen, F., Gardner, L., Radovich, M., Li, L., Miller, K. D., Jiang, G., Lai, D., O'Neill, A., Sparano, J. A., Davidson, N. E., Cameron, D., Gradus-Pizlo, I., Mastouri, R. A., Suter, T. M., Foroud, T. & Sledge, G. W., Jan 1 2017, In : Clinical Cancer Research. 23, 1, p. 43-51 9 p.

Research output: Contribution to journalArticle

22 Scopus citations

High expression of FGD3, a putative regulator of cell morphology and motility, is prognostic of favorable outcome in multiple cancers

Willis, S., Sun, Y., Abramovitz, M., Fei, T., Young, B., Lin, X., Ni, M., Achua, J., Regan, M. M., Gray, K. P., Gray, R., Wang, V., Long, B., Kammler, R., Sparano, J. A., Williams, C., Goldstein, L. J., Salgado, R., Loi, S., Pruneri, G. & 3 others, Viale, G., Brown, M. & Leyland-Jones, B., Jan 1 2017, In : JCO Precision Oncology. 2017, 1, p. 1-13 13 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Impact of genetic ancestry on outcomes in ECOG-ACRIN-5103

Schneider, B. P., Shen, F., Jiang, G., O'Neill, A., Radovich, M., Li, L., Gardner, L., Lai, D., Foroud, T., Sparano, J. A., Sledge, G. W. & Miller, K. D., 2017, In : JCO Precision Oncology. 2017, 1, p. 1-9 9 p.

Research output: Contribution to journalArticle

4 Scopus citations

Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism

Karagiannis, G. S., Pastoriza, J. M., Wang, Y., Harney, A. S., Entenberg, D., Pignatelli, J., Sharma, V. P., Xue, E. A., Cheng, E., D'Alfonso, T. M., Jones, J. G., Anampa, J., Rohan, T. E., Sparano, J. A., Condeelis, J. S. & Oktay, M. H., Jul 5 2017, In : Science translational medicine. 9, 397, aan0026.

Research output: Contribution to journalArticle

129 Scopus citations

Randomized phase II study of ramucirumab or icrucumab in combination with capecitabine in patients with previously treated locally advanced or metastatic breast cancer

Vahdat, L. T., Layman, R., Yardley, D. A., Gradishar, W., Salkeni, M. A., Joy, A. A., Garcia, A. A., Ward, P., Khatcheressian, J., Sparano, J., Rodriguez, G., Tang, S., Gao, L., Dalal, R. P., Kauh, J. & Miller, K., Mar 2017, In : Oncologist. 22, 3, p. 245-254 10 p.

Research output: Contribution to journalArticle

7 Scopus citations

The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance

Suarez, C. D., Wu, J., Badve, S. S., Sparano, J. A., Kaliney, W. & Littlepage, L. E., 2017, In : Oncotarget. 8, 65, p. 108534-108547 14 p.

Research output: Contribution to journalArticle

2016

A phase 1b/pharmacokinetic trial of PTC299, a novel posttranscriptional VEGF inhibitor, for AIDS-related Kaposi's Sarcoma: AIDS malignancy consortium trial 059

for the AIDS Malignancy Consortium (AMC)-059 Study Team, May 1 2016, In : Journal of Acquired Immune Deficiency Syndromes. 72, 1, p. 52-57 6 p.

Research output: Contribution to journalArticle

3 Scopus citations

Central nervous system involvement in AIDS-related lymphomas

Barta, S. K., Joshi, J., Mounier, N., Xue, X., Wang, D., Ribera, J. M., Navarro, J. T., Hoffmann, C., Dunleavy, K., Little, R. F., Wilson, W. H., Spina, M., Galicier, L., Noy, A. & Sparano, J. A., Jun 1 2016, In : British Journal of Haematology. 173, 6, p. 857-866 10 p.

Research output: Contribution to journalArticle

4 Scopus citations

Charcot-Marie-Tooth gene, SBF2, associated with taxaneinduced peripheral neuropathy in African Americans

Schneider, B. P., Lai, D., Shen, F., Jiang, G., Radovich, M., Li, L., Gardner, L., Miller, K. D., O'Neill, A., Sparano, J. A., Xue, G., Foroud, T. & Sledge, G. W., 2016, In : Oncotarget. 7, 50, p. 82244-82253 10 p.

Research output: Contribution to journalArticle

17 Scopus citations

Clinical and Translational Results of a Phase II, Randomized Trial of an AntiIGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

Gradishar, W. J., Yardley, D. A., Layman, R., Sparano, J. A., Chuang, E., Northfelt, D. W., Schwartz, G. N., Youssoufian, H., Tang, S., Novosiadly, R., Forest, A., Nguyen, T. S., Cosaert, J., Grebennik, D. & Haluska, P., Jan 15 2016, In : Clinical Cancer Research. 22, 2, p. 301-309 9 p.

Research output: Contribution to journalArticle

25 Scopus citations

In Regard to Bruner et al

Ohri, N., Kalnicki, S., Sparano, J. A. & Garg, M. K., Apr 1 2016, In : International Journal of Radiation Oncology Biology Physics. 94, 5, p. 1220-1221 2 p.

Research output: Contribution to journalArticle

Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial)

Epeldegui, M., Lee, J. Y., Martínez, A. C., Widney, D. P., Magpantay, L. I., Regidor, D., Mitsuyasu, R., Sparano, J. A., Ambinder, R. F. & Martínez-Maza, O., Jan 15 2016, In : Clinical Cancer Research. 22, 2, p. 328-336 9 p.

Research output: Contribution to journalArticle

6 Scopus citations

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: A New York cancer consortium trial

Adelson, K., Ramaswamy, B., Sparano, J. A., Christos, P. J., Wright, J. J., Raptis, G., Han, G., Villalona-Calero, M., Ma, C. X., Hershman, D., Baar, J., Klein, P., Cigler, T., Budd, G. T., Novik, Y., Tan, A. R., Tannenbaum, S., Goel, A., Levine, E., Shapiro, C. L. & 5 others, Andreopoulou, E., Naughton, M., Kalinsky, K., Waxman, S. & Germain, D., Dec 14 2016, In : npj Breast Cancer. 2, 1, 16037.

Research output: Contribution to journalArticle

Open Access
10 Scopus citations

Reply to C. Shah et al

Solin, L. J., Gray, R., Hughes, L. L., Wood, W. C., Lowen, M. A., Badve, S. S., Baehner, F. L., Ingle, J. N., Perez, E. A., Recht, A., Sparano, J. A. & Davidson, N. E., May 20 2016, In : Journal of Clinical Oncology. 34, 15, p. 1824-1825 2 p.

Research output: Contribution to journalArticle

Risk of Recurrence and Mortality in a Multi-Ethnic Breast Cancer Population

Kabat, G. C., Ginsberg, M. S., Sparano, J. A. & Rohan, T. E., Dec 21 2016, (Accepted/In press) In : Journal of racial and ethnic health disparities. p. 1-8 8 p.

Research output: Contribution to journalArticle

4 Scopus citations